Form 4: Hims & Hers Health Chief Legal Officer Soleil Boughton Executes Stock Options and Sells Shares

Sentiment:

SEC Form 4 Filing


Soleil Boughton, Chief Legal Officer of Hims & Hers Health, exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., executed stock options to acquire 129,667 shares of Class A Common Stock at a price of $5.01 per share on May 30, 2024.
  • Concurrently, Boughton sold a total of 129,667 shares of Class A Common Stock in two separate transactions.
  • The first sale involved 114,460 shares at a weighted average price of $20.4724, with prices ranging from $20.00 to $20.99.
  • The second sale involved 15,207 shares at a weighted average price of $21.1727, with prices ranging from $21.00 to $21.40.
  • These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted by Boughton on September 10, 2023.
  • Following these transactions, Boughton directly owns 156,855 shares of Class A Common Stock and 834,409 stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions are part of a pre-planned trading strategy and do not necessarily indicate a positive or negative outlook on the company's performance.

Positives

  • The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.

Industry Context

Insider transactions are common and closely monitored, especially in publicly traded companies like Hims & Hers Health. The use of a 10b5-1 plan indicates a pre-planned strategy for these transactions.

Comparison to Industry Standards

  • Monitoring insider trading activity is standard practice in the financial industry.
  • Companies like Teledoc and Amwell, which operate in similar telehealth spaces, are also subject to insider trading regulations and reporting requirements.
  • The reported transactions are typical for executives holding stock options and utilizing 10b5-1 plans for orderly sales.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
  • However, the pre-planned nature of the sales mitigates concerns about insider information being used for personal gain.

Key Dates

DateDescription
09/10/2023Date of adoption of Rule 10b5-1 trading plan
05/30/2024Date of stock option exercise and share sales
06/03/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.